Cargando…
Commentary: A GSH/CB dual-controlled self-assembled nanomedicine for high-efficacy doxorubicin-resistant breast cancer therapy
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744131/ https://www.ncbi.nlm.nih.gov/pubmed/36518660 http://dx.doi.org/10.3389/fphar.2022.1081912 |
| _version_ | 1784848852495368192 |
|---|---|
| author | Tian, Tian |
| author_facet | Tian, Tian |
| author_sort | Tian, Tian |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9744131 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97441312022-12-13 Commentary: A GSH/CB dual-controlled self-assembled nanomedicine for high-efficacy doxorubicin-resistant breast cancer therapy Tian, Tian Front Pharmacol Pharmacology Frontiers Media S.A. 2022-11-28 /pmc/articles/PMC9744131/ /pubmed/36518660 http://dx.doi.org/10.3389/fphar.2022.1081912 Text en Copyright © 2022 Tian. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Tian, Tian Commentary: A GSH/CB dual-controlled self-assembled nanomedicine for high-efficacy doxorubicin-resistant breast cancer therapy |
| title | Commentary: A GSH/CB dual-controlled self-assembled nanomedicine for high-efficacy doxorubicin-resistant breast cancer therapy |
| title_full | Commentary: A GSH/CB dual-controlled self-assembled nanomedicine for high-efficacy doxorubicin-resistant breast cancer therapy |
| title_fullStr | Commentary: A GSH/CB dual-controlled self-assembled nanomedicine for high-efficacy doxorubicin-resistant breast cancer therapy |
| title_full_unstemmed | Commentary: A GSH/CB dual-controlled self-assembled nanomedicine for high-efficacy doxorubicin-resistant breast cancer therapy |
| title_short | Commentary: A GSH/CB dual-controlled self-assembled nanomedicine for high-efficacy doxorubicin-resistant breast cancer therapy |
| title_sort | commentary: a gsh/cb dual-controlled self-assembled nanomedicine for high-efficacy doxorubicin-resistant breast cancer therapy |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744131/ https://www.ncbi.nlm.nih.gov/pubmed/36518660 http://dx.doi.org/10.3389/fphar.2022.1081912 |
| work_keys_str_mv | AT tiantian commentaryagshcbdualcontrolledselfassemblednanomedicineforhighefficacydoxorubicinresistantbreastcancertherapy |